Table of Content


Table of Contents
Introduction
Ventilator Associated Pneumonia (VAP) - Overview
Ventilator Associated Pneumonia (VAP) - Therapeutics Development
Ventilator Associated Pneumonia (VAP) - Therapeutics Assessment
Ventilator Associated Pneumonia (VAP) - Companies Involved in Therapeutics Development
Ventilator Associated Pneumonia (VAP) - Drug Profiles
Ventilator Associated Pneumonia (VAP) - Dormant Projects
Ventilator Associated Pneumonia (VAP) - Discontinued Products
Ventilator Associated Pneumonia (VAP) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Ventilator Associated Pneumonia (VAP), H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products by Top 10 Targets, H1 2019
Number of Products by Stage and Top 10 Targets, H1 2019
Number of Products by Top 10 Mechanism of Actions, H1 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019
Number of Products by Routes of Administration, H1 2019
Number of Products by Stage and Routes of Administration, H1 2019
Number of Products by Molecule Types, H1 2019
Number of Products by Stage and Molecule Types, H1 2019


List of Tables


Number of Products under Development for Ventilator Associated Pneumonia (VAP), H1 2019
Number of Products under Development by Companies, H1 2019
Products under Development by Companies, H1 2019
Products under Development by Companies, H1 2019 (Contd..1), H1 2019
Number of Products by Stage and Target, H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019
Number of Products by Stage and Route of Administration, H1 2019
Number of Products by Stage and Molecule Type, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Aridis Pharmaceuticals Inc, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by AstraZeneca Plc, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Cumberland Pharmaceuticals Inc, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by CytaCoat AB, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Destiny Pharma Plc, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Dong-A Socio Holdings Co Ltd, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Evaxion Biotech ApS, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by MedImmune LLC, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Meiji Seika Pharma Co Ltd, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Merck & Co Inc, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Motif Bio Plc, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Nabriva Therapeutics Plc, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Polyphor AG, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Shionogi & Co Ltd, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Spero Therapeutics Inc, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Tetraphase Pharmaceuticals Inc, H1 2019
Ventilator Associated Pneumonia (VAP) - Pipeline by Wockhardt Ltd, H1 2019
Ventilator Associated Pneumonia (VAP) - Dormant Projects, H1 2019
Ventilator Associated Pneumonia (VAP) - Discontinued Products, H1 2019